acebutolol has been researched along with rifampin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Corpe, WA; Guffanti, AA | 1 |
| Hyun, HH; Zeikus, JG | 1 |
| McKay, LL; Polzin, KM; Steele, JL | 1 |
| Chao, J; Weathersbee, CJ | 1 |
| Leng, FF; Li, HY; Liang, S; Lu, JF; Sun, HL; Zhu, Y | 1 |
| Kadota, K | 1 |
| Carr, CR; Garhyan, J; Pohane, AA; Siegrist, MS; Swarts, BM | 1 |
2 review(s) available for acebutolol and rifampin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Design of Spray-dried Porous Particles for Sugar-based Dry Powder Inhaler Formulation].
Topics: Administration, Inhalation; Antitubercular Agents; Carboxylic Acids; Dextrins; Drug Compounding; Drug Delivery Systems; Drug Design; Dry Powder Inhalers; Ethanol; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Isoniazid; Maltose; Naphthalenes; Particle Size; Porosity; Powders; Rifampin; Solutions; Sucrose | 2018 |
14 other study(ies) available for acebutolol and rifampin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Maltose metabolism of Pseudomonas fluorescens.
Topics: Cell-Free System; Chloramphenicol; Dactinomycin; Enzyme Induction; Glucose; Glucosidases; Hydrogen-Ion Concentration; Hydrolysis; Maltose; Pseudomonas fluorescens; Rifampin | 1975 |
Regulation and genetic enhancement of beta-amylase production in Clostridium thermosulfurogenes.
Topics: Amylases; beta-Amylase; Cellobiose; Clostridium; Cyclic AMP; Deoxyglucose; Fermentation; Fructose; Gene Expression Regulation; Glucose; Maltose; Mutation; Rifampin; Species Specificity; Sucrose; Tetracycline; Xylose | 1985 |
Characterization of the genetic element coding for lactose metabolism in Lactococcus lactis subsp. lactis KP3.
Topics: Bacteriophages; Conjugation, Genetic; Deoxyribonuclease EcoRI; Erythromycin; Genes, Bacterial; Lactococcus lactis; Lactose; Lactose Factors; Maltose; Mutation; Nucleic Acid Hybridization; Phenotype; Plasmids; Recombination, Genetic; Rifampin; Streptomycin; Transformation, Bacterial | 1989 |
Regulation of maltodextrin phosphorylase synthesis in Escherichia coli by cyclic adenosine 3', 5'-monophosphate and glucose.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Bucladesine; Carbon Radioisotopes; Cell-Free System; Cyclic AMP; Enzyme Induction; Enzyme Repression; Escherichia coli; Glucose; Glucosyltransferases; Maltose; Membrane Transport Proteins; Phosphorylases; Rifampin; RNA, Messenger; Transcription, Genetic | 1974 |
Highly efficient production of hyaluronic acid by Streptococcus zooepidemicus R42 derived from heterologous expression of bacterial haemoglobin and mutant selection.
Topics: Acetic Acid; Biomass; Fermentation; Glutamic Acid; Hemoglobins; Hyaluronic Acid; Lactic Acid; Maltose; Methylnitronitrosoguanidine; Rifampin; Streptococcus equi; Sucrose | 2016 |
Trehalose Recycling Promotes Energy-Efficient Biosynthesis of the Mycobacterial Cell Envelope.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Cell Membrane; Cell Wall; Cord Factors; Diarylquinolines; Energy Metabolism; Galactans; Gene Expression; Glucose; Maltose; Membrane Transport Proteins; Mycobacterium smegmatis; Mycobacterium tuberculosis; Mycolic Acids; Rifampin; Trehalose | 2021 |